Streptococcus Pneumoniae Infections
📧 Sign up to get email alerts when something new happens for Streptococcus Pneumoniae Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine [Phase 3]
This clinical trial update indicates that a Phase 3 study of the combined administration of a 15-valent pneumococcal conjugate vaccine and a…
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A [Phase 3]
Phase 3 trial update on a GlaxoSmithKline pneumococcal conjugate vaccine (1024850A) reporting its immunogenicity, safety, and impact on carr…
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine [Phase 3]
Phase 3 clinical trial updating antibody persistence in children previously vaccinated with pneumococcal conjugate vaccine; results complete…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine [Phase 3]
Phase 3 trial update assessing immunogenicity of GSK's 10-valent pneumococcal conjugate vaccine has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-30Clinical Trial Update: Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004) [Phase 1, Phase 2]
A Phase 1/2 trial evaluating safety, tolerability, and immunogenicity of the V114 pneumococcal vaccine in healthy adults and infants complet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants. [Phase 3]
A Phase 3 clinical trial evaluated safety and immunogenicity of a booster dose of pneumococcal conjugate vaccine in preterm born infants; re…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™ [Phase 3]
Phase 3 clinical trial evaluating vaccination with GSK 1024850A in children primed with GSK 1024850A and boosted with Pneumovax 23, with com…
-
CLINICAL_TRIALS trial_result · 2012-05-10Clinical Trial Update: Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age [Phase 3]
Phase 3 trial update of a pneumococcal conjugate vaccine in healthy infants aged 6 to 12 weeks; trial completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2011-09-30Clinical Trial Update: Study of Two Investigational Pneumococcal Vaccines in Healthy Adults [Phase 1]
A Phase 1 study evaluating two investigational pneumococcal vaccines in healthy adults has completed.
-
CLINICAL_TRIALS trial_result · 2010-10-29Clinical Trial Update: Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age [Phase 3]
A Phase 3 trial evaluated primary vaccination with a pneumococcal conjugate vaccine in healthy infants aged 6 to 10 weeks; study completed w…